Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Impact of chronic obstructive pulmonary disease on the efficacy and safety of neoadjuvant immune checkpoint inhibitors combined with chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study

Fig. 2

Comparison of (A) R0 resection rate, (B) Response of lymph node(N2), (C) Treatment response, (D) Objective response rate, (E) Pathological complete response and (F) Major pathological response of NSCLC patients receiving neoadjuvant ICI combined with chemotherapy between the COPD and the non-COPD group

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us